Could psychedelics tackle the obesity crisis? A longtime researcher in the field says his latest mouse study suggests potential

Jason Mast

Editor

Psychedelics have experienced a renaissance i n recent years amid a torrent of preclinical and clinical research suggesting it might provide a path to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Could psychedelics tackle the obesity crisis? A longtime researcher in the field says his latest mouse study suggests potential

Jason Mast

Editor

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure

The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease

New CBER chief Prasad is readying 'massive framework' around vaccines, Makary says

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

Eli Lilly turns to South Korean RNA editing biotech for hearing loss in deal worth $1.3B

Exclusive: Drug compounder Empower was built on risky shortcuts, ex-employees and inspections allege

Could psy­che­delics tack­le the obe­si­ty cri­sis? A long­time re­searcher in the field says his lat­est mouse study sug­gests po­ten­tial

Editor

Sign up to read this article for free.

more like this

Celldex Therapeutics

Hampton, NJ, USA

Could psychedelics tackle the obesity crisis? A longtime researcher in the field says his latest mouse study suggests potential